Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Accounts Payables (2020 - 2026)

Nuvalent's (NUVL) quarterly Accounts Payables came in at $22.1 million in Q1 2026, down 15.4% YoY from $26.2 million in Q1 2025, and down 26.6% on a QoQ basis from $30.2 million in Q4 2025.

Analysis

Nuvalent (NUVL) Accounts Payables (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Accounts Payables data on file, last reported at $22.1 million in Q1 2026.

  • Quarterly Accounts Payables fell 15.4% year-over-year to $22.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 million (down 15.4% YoY) and the FY2025 annual result came in at $30.2 million, up 477.19% from the prior year.
  • Accounts Payables slipped to $22.1 million in Q1 2026, from $30.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $30.2 million in Q4 2025 to a low of $4.0 million in Q2 2022.
  • A 5-year average of $12.3 million and a median of $9.3 million in 2023 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2024 — Accounts Payables plunged 43.66% — and 2025, when it surged 477.19%.
  • Tracing NUVL's Accounts Payables over 5 years: stood at $7.2 million in 2022, then gained by 28.9% to $9.3 million in 2023, then plunged by 43.66% to $5.2 million in 2024, then surged by 477.19% to $30.2 million in 2025, then fell by 26.6% to $22.1 million in 2026.
  • The last three Accounts Payables figures came in at $22.1 million (Q1 2026), $30.2 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 22.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 22.14 Mn
Dec 31, 2025 30.16 Mn
Sep 30, 2025 22.01 Mn
Jun 30, 2025 13.34 Mn
Mar 31, 2025 26.17 Mn
Dec 31, 2024 5.23 Mn
Sep 30, 2024 15.93 Mn
Jun 30, 2024 7.40 Mn
Mar 31, 2024 13.40 Mn
Dec 31, 2023 9.27 Mn
Sep 30, 2023 9.78 Mn
Jun 30, 2023 8.12 Mn
Mar 31, 2023 6.43 Mn
Dec 31, 2022 7.20 Mn
Sep 30, 2022 4.62 Mn
Jun 30, 2022 4.03 Mn
Mar 31, 2022 4.25 Mn
Dec 31, 2021 2.89 Mn
Sep 30, 2021 2.53 Mn
Jun 30, 2021 3.80 Mn